Clinical efficacy and tolerability of a steady dosage schedule of local nasal immunotherapy. Results of preseasonal treatment in grass pollen rhinitis
- 31 January 1999
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 82 (1), 47-51
- https://doi.org/10.1016/s1081-1206(10)62659-2
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Measurement of serum levels of eosinophil cationic protein to monitor patients with seasonal respiratory allergy induced by Parietaria pollen (treated and untreated with specific immunotherapy)Allergy, 1996
- Local nasal immunotherapy with extract in powder form is effective and safe in grass pollen rhinitis: A double-blind studyJournal of Allergy and Clinical Immunology, 1996
- Local immunotherapy is not documented for clinical useAllergy, 1994
- Local nasal immunotherapy for Dermatophagoides-induced rhinitis: Efficacy of a powder extractJournal of Allergy and Clinical Immunology, 1993
- Local nasal immunotherapy in allergic rhinitis to ParietariaAllergy, 1992
- RhinomanometryJournal of Allergy and Clinical Immunology, 1989
- Zur Sensitivität und Spezifität der intranasalen ProvokationLaryngo-Rhino-Otologie, 1988
- Local nasal immunotherapy for ragweed‐allergic rhinitisClinical and Experimental Allergy, 1983
- Allergen-controlled study of intranasal immunotherapy for ragweed hay feverJournal of Allergy and Clinical Immunology, 1983
- Local intranasal immunotherapy for ragweed allergic rhinitis II. Immunologic responseJournal of Allergy and Clinical Immunology, 1981